Capsaicin induces apoptosis of cisplatin-resistant stomach cancer cells by causing degradation of cisplatin-inducible aurora-A protein

Nutrition and Cancer

Volumn 63, Issue 7, 2011, Pages 1095-1103

  Huh, Hui Chung ^a   Lee, Sun Young ^b   Lee, Seung Keun ^a   Park, Neung Hwa ^c   Han, In Seob ^a  

^a University of Ulsan   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; CAPSAICIN; CISPLATIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DEATH; DOWN REGULATION; DRUG RESISTANCE; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MITOSIS; PROTEIN DEGRADATION; STOMACH CANCER;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CAPSAICIN; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; HUMANS; I-KAPPA B PROTEINS; NF-KAPPA B; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; STOMACH NEOPLASMS;

CAPSICUM ANNUUM VAR. ANNUUM;

EID: 80053625806     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2011.607548     Document Type: Article

References (46)

1. Jansen BA, Brouwer J, and Reedijk J: Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs. J Inorg Biochem 89, 197-202, 2002. (Pubitemid 34327260)
2. Siddik ZH: Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22, 7265-7279, 2003. (Pubitemid 37487159)
3. Arts HJ, Willemse PH, Tinga DJ, de Vries EG, and van der Zee AG: Laparoscopic placement of PAP catheters for intraperitoneal chemotherapy in ovarian carcinoma. Gynecol Oncol 69, 32-35, 1998. (Pubitemid 28201668)
4. Lee S, Choi EJ, Jin C, and Kim DH: Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line. Gynecol Oncol 97, 26-34, 2005. (Pubitemid 40403670)
5. Rudin CM, Yang Z, Schumaker LM, Vander Weele DJ, Newkirk K, et al.: Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance. Cancer Res 63, 312-318, 2003. (Pubitemid 36152486)
6. Weir NM, Selvendiran K, Kutala VK, Tong L, Vishwanath S, et al.: Induces G(2)/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol Ther 6, 178-184, 2007. (Pubitemid 46641620)
7. Bratasz A, Weir NM, Parinandi NL, Zweier JL, Sridhar R, et al.: Reversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirin. Proc Natl Acad Sci USA 103, 3914-3919, 2006. (Pubitemid 43376655)
8. Piccirillo MC, Daniele G, Di Maio M, Bryce J, De Feo G, et al.: Vinorelbine for non-small cell lung cancer. Expert Opin Drug Saf 9, 493-510, 2010.
9. Wagner AD, Unverzagt S, Grothe W, Kleber G, Grothey A, et al.: Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev 3, CD004064, 2010.
10. Liao ML, Zhu YZ, Li LY, Wan HY, Yu SY, et al.: Gemcitabine and cisplatin treatment over a 3-week versus a 4-week dosing schedule: a randomized trial conducted in Chinese patients with nonsmall cell lung cancer. Chin Med J (Engl), 121, 892-897, 2008.
11. Park JH, Jong HS, Kim SG, Jung Y, Lee KW, et al.: Inhibitors of his-tone deacetylases induce tumor-selective cytotoxicity through modulating Aurora-A kinase. J Mol Med 86, 117-128, 2008.
12. Harrington EA, Bebbington D, Moore J, Rasmussen RK, Ajose-Adeogun AO, et al.: VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat Med 10, 262-267, 2004. (Pubitemid 38667616)
13. Briassouli P, Chan F, Savage K, Reis-Filho JS, Linardopoulos S, et al.: Regulation of nuclear factor-κB signaling by phosphorylation of IκBα. Cancer Res 67, 1689-1695, 2007. (Pubitemid 46383395)
14. Zhang J, Nagasaki M, Tanaka Y, and Morikawa S: Capsaicin inhibits growth of adult T-cell leukemia cells. Leuk Res 27, 275-283, 2003. (Pubitemid 36132118)
15. Kim JD, Kim JM, Pyo JO, Kim SY, Kim BS, et al.: Capsaicin can alter the expression of tumor forming-related genes which might be followed by induction of apoptosis of a Korean stomach cancer cell line, SNU-1. Cancer Lett 120, 235-241, 1997.
16. Huang SP, Chen JC, Wu CC, Chen CT, Tang NY, et al.: Capsaicin-induced apoptosis in human hepatoma HepG2 cells. Anticancer Res 29, 165-174, 2009.
17. Lee YS, Nam DH, and Kim JA: Induction of apoptosis by capsaicin in A172 human glioblastoma cells. Cancer Lett 161, 121-130, 2000.
18. Jung MY, Kang HJ, and Moon A: Capsaicin-induced apoptosis in SK-Hep-1 hepatocarcinoma cells involves Bcl-2 downregulation and caspase-3 activation. Cancer Lett 165, 139-145, 2001. (Pubitemid 32244170)
19. Kim SY, Lee YJ, Park EH, Yi HK, Jo DS, et al.: Capsaicin induced apoptosis and the enhanced anticancer effect of anticancer drugs in cancer cells. Korean J Pediatrics 51, 307-314, 2008.
20. Qin L, Tong T, Song Y, Xue L, Fan F, et al.: Aurora-A interacts with cyclin B1 and enhances its stability. Cancer Lett 275, 77-85, 2009.
21. Surh YJ, Lee RC, Park KK, Mayne ST, Liem A, et al.: Chemoprotective effects of capsaicin and diallyl sulfide against mutagenesis or tumorigen-esis by vinyl carbamate and N-nitrosodimethylamine. Carcinogenesis 16, 2467-2471, 1995.
22. Huynh HT and Teel RW: In vitro antimutagenicity of capsaicin toward heterocyclic amines in Salmonella typhimurium strain TA98. Anticancer Res 25, 117-120, 2005. (Pubitemid 40470099)
23. Kim JY, Kim EH, Kim SU, Kwon TK, and Choi KS: Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation. Carcinogenesis 31, 367-375, 2010.
24. Wu CC, Lin JP, Yang JS, Chou ST, Chen SC, et al.: Capsaicin induced cell cycle arrest and apoptosis in human esophagus epidermoid carcinoma CE 81T/VGH cells through the elevation of intracellular reactive oxygen species and Ca2+ productions and caspase-3 activation. Mutat Res 601, 71-82, 2006.
25. Wang XX, Liu R, Jin SQ, Fan FY, and Zhan QM: Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line. Cell Res 16, 356-366, 2006.
26. Yang H, He L, Kruk P, Nicosia SV, and Cheng JQ: Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells. Int J Cancer 119, 2304-2312, 2006. (Pubitemid 44546949)
27. Maldonado V, Melendez-Zajgla J, and Ortega A: Modulation of NF-kappa B, and Bcl-2 in apoptosis induced by cisplatin in HeLa cells. Mutat Res 381, 67-75, 1997. (Pubitemid 27504568)
28. Venkatraman M, Anto RJ, Nair A, Varghese M, and Karunagaran D: Biological and chemical inhibitors of NF-kappaB sensitize SiHa cells to cisplatin-induced apoptosis. Mol Carcinog 44, 51-59, 2005. (Pubitemid 41216407)
29. Strozyk E, Poppelmann B, Schwarz T, and Kulms D: Differential effects of NF-kappaB on apoptosis induced by DNA-damaging agents: the type of DNA damage determines the final outcome. Oncogene 25, 6239-6251, 2006. (Pubitemid 44564741)
30. Lu YS, Yeh PY, Chuang SE, Gao M, Kuo ML, et al.: Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-{kappa}B activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa. J Endocrinol 188, 311-319, 2006. (Pubitemid 43273819)
31. Kim J, Kang M, Lee JS, Inoue M, Sasazuki S, et al.: Fermented and non-fermented soy food consumption and gastric cancer in Japanese and Korean populations: a meta-analysis of observational studies. Cancer Sci 102, 231-244, 2011.
32. Strathdee G, Sansom OJ, Sim A, Clarke AR, and Brown R: A role for mismatch repair in control of DNA ploidy following DNA damage. Oncogene 20, 1923-1927, 2001. (Pubitemid 32458702)
33. Eastman A, Kohn EA, Brown MK, Rathman J, Livingstone M, et al.: A novel indolocarbazole, ICP-1, abrogates DNA damage-induced cell cycle arrest and enhances cytotoxicity: similarities and differences to the cell cycle checkpoint abrogator UCN-01. Mol Cancer Ther 1, 1067-1078, 2002.
34. Katayama H, Sasai K, Kawai H, Yuan ZM, Bondaruk J, et al.: Phospho-rylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet 36, 55-62, 2004. (Pubitemid 38056208)
35. Lin YG, Immaneni A, Merritt WM, Mangala LS, Kim SW, et al.: Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth. Clin Cancer Res 14, 5437-5446, 2008.
36. Gautschi O, Heighway J, Mack PC, Purnell PR, Lara PN, Jr., Gandara DR: Aurora kinases as anticancer drug targets. Clin Cancer Res 14, 1639-48, 2008. (Pubitemid 351471713)
37. Du J and Hannon GJ: Suppression of p160ROCK bypasses cell cycle arrest after Aurora-A/STK15 depletion. Proc Natl Acad Sci USA 101, 8975-8980, 2004. (Pubitemid 38781596)
38. Wang HM, Chueh PJ, Chang SP, Yang CL, and Shao KN: Effectofcapsaicin on tNOX (ENOX2) protein expression in stomach cancer cells. Biofactors 34, 209-217, 2009.
39. Chow J, Norng M, Zhang J, and Chai J: TRPV6 mediates capsaicin-induced apoptosis in gastric cancer cells-mechanisms behind a possible new "hot" cancer treatment. Biochim Biophys Acta 1773, 565-576, 2007. (Pubitemid 46441507)
40. Carpinelli P, Ceruti R, Giorgini ML, Cappella P, Gianellini L, et al.: PHA-739358, apotent inhibitorofAurora kinases withaselective target inhibition profile relevant to cancer. Mol Cancer Ther 6, 3158-3168, 2007.
41. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, et al.: A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. Embo J 17, 3052-3065, 1998. (Pubitemid 28254378)
42. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, et al.: Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy, and transformation. Nat Genet 20, 189-193, 1998. (Pubitemid 28455454)
43. Castro A, Arlot-Bonnemains Y, Vigneron S, Labbe JC, Prigent C, et al.: APC/Fizzy-related targets Aurora-A kinase for proteolysis. EMBO Rep 3, 457-62, 2002. (Pubitemid 34567434)
44. Taguchi S, Honda K, Sugiura K, Yamaguchi A, Furukawa K, et al.: Degradation of human Aurora-A protein kinase is mediated by hCdh1. FEBS Lett 519, 59-65, 2002. (Pubitemid 34521992)
45. Crane R, Kloepfer A, and Ruderman JV: Requirements for the destruction of human Aurora-A. J Cell Sci 117, 5975-5983, 2004. (Pubitemid 40123964)
46. Sancho R, Lucena C, Macho A, Calzado MA, Blanco-Molina M, et al.: Immunosuppressive activity of capsaicinoids: capsiate derived from sweet peppers inhibits NF-kappaB activation and is a potent antiinflammatory compound in vivo. Eur J Immunol 32, 1753-1763, 2002. (Pubitemid 34679163)